Mechanism of the Protective Effect of Sesamin on Sepsis-Induced Acute Lung Injury.

Citation metadata

Date: May 2021
Publisher: New Century Health Publishers, LLC
Document Type: Article
Length: 3,458 words
Lexile Measure: 1330L

Document controls

Main content

Abstract :

Sepsis is the syndrome of systemic inflammatory response caused by infection. Over 20 million people worldwide suffer from sepsis each year, of whom aPout 6 million die, with a case-fatality rate of more than 25%. Therefore, to develop a rational plan for the management of sepsis, there is an urgent need to understand the mechanism of pathogenesis. Sesamin is a kind of sesame lignin isolated from sesame that exhibits multiple Piological functions including antiviral, antidyslipidemic, and antihypertensive to name a few. An antioxidant and anti-inflammatory activity of sesamin appears to be a common denominator in all of its biologic activities. However, the mechanism of sesamin on septic-induced acute pulmonary inflammation still needs further study. Herein, we have established a sepsis model of C57BL/6 mice by cecal ligation and perforation. Using this model, we have shown that sesamin could reduce the levels of several inflammatory factors as well as oxidative stress response. Furthermore, sesamin could repress NLRP3 inflammasome and activate Nrf2/HO-1 pathway, and further inhibit acute pulmonary inflammation. This study reveals the mechanism of the diminution of septic-induced acute pulmonary inflammation by sesamin. This opens a theoretical basis for the development of drugs for treatment of sepsis. Keywords: Acute pulmonary inflammation, Nrf2/HO-1 pathway, Oxidative stress, Sepsis, Sesamin Abbreviations Used: Acute lung injury, ALI; Analysis of variance, ANOVA; Bronchoalveolar lavage fluid, BALF; Cecal ligation and puncture, CLP; Enzyme-linked immunosorbent assay, ELISA; Glutathione, GSH; Heme oxygenase; HO-1, Lactate dehydrogenase, LDH; Lipopolysaccharide, LPS; Malondialdehyde, MDA; Myeloperoxidase, MPO; Nuclear factor kappa-light-chain-enhancer of activated B cells, NF-[kappa]B; Nucleotide-binding domain and leucine-rich repeat containing protein family with pyrin domain containing protein 3, NLRP3; Nuclear-factor erythroid 2-related factor 2; Nrf2, Nuclear-factor erythroid 2-related factor 2/Heme oxygenase-1, Nrf2/HO-1; Radioimmunoprecipitation assay buffer, RIPA buffer; Reactive oxygen species, ROS; Reduced glutathione, GSH; Sodium dodecyl sulfate-polyacrylamide gel electrophoresis, SDS-PAGE; Superoxide dismutase, SOD; Toll-like receptor 4, TLR4; Wet weight/Dry weight ratio, W/D ratio Corresponding Author: Dr. Qian Liu, Emergency Ward, Lishui Hospital of TCM, No. 800 Zhongshan Street, Wanxiang Street, Lishui City, Zhejiang Province, China; E-mail:

Source Citation

Source Citation   

Gale Document Number: GALE|A659273156